Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
NKGN
1000% explosion coming sooner than I anticipated
Alzheimer and Parkinson’s market is more than $60 billion worldwide
1000% explosion coming sooner than I anticipated
Alzheimer and Parkinson’s market is more than $60 billion worldwide
NKGN
keep going up
Huge data presentation next week
$4 PT next week
NKGN
exploding in anticipation of Parkinson’s and Alzheimer presentation next week
Billion dollars stock trading $25 mil mktcap
1000% explosion coming
NKGN
moving up from bottom
Huge presentation next week
$2 PT next week
NKGN
billion dollars market company trading at $15 mil mktcap
Huge data presentation for Parkinson’s and Alzheimer next week
NKGN is worth billion dollars based on P1 result of Alzheimer and preclinical result of Pakinson disease
Super explosion upon the data explosion next week
NKGN
Huge presentation for Parkinson’s and Alzheimer next week
Rock bottom Pps
NKGen Biotech Announces Upcoming Presentation on SNK01 NK Cell Therapy in Neurodegenerative Disease at the 12th Annual Alzheimer's & Parkinson's Drug Development Summit
Mentioned: NKGN
GlobeNewswireApril 18, 2024
SANTA ANA, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) ("NKGen" or the "Company"), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer ("NK") cell therapeutics, today announced that Paul Y. Song, MD, Chairman and Chief Executive Officer of NKGen Biotech, will present details around its NK cell therapy in neurodegenerative disease, review its preclinical data in Parkinson's disease, and highlight clinical safety and efficacy data from the Company's recently completed Phase 1 clinical trial of SNK01, autologous natural killer cell therapy, in Alzheimer's disease at the 12th Annual Alzheimer's & Parkinson's Drug Development Summit to be held in Boston, MA, from April 23-25, 2024.
Presentation Details:
Title: Evaluating Adoptive Cellular Immunotherapy for Neurodegeneration with Autologous SNK01
Conference Track: Translational -- Harnessing Cell Therapy & Senescence to Reduce Alzheimer's Pathology in Preclinical Research
Date and Time: Thursday, April 25, 2024, 2:00 pm ET
Dr. Song's presentation will detail how enhanced natural killer cells can maximize the body's ability to destroy diseased and abnormal cells and provide a review of NK cell therapy as an alternative treatment modality to resolve neurodegeneration by harnessing the body's natural immune system, including a discussion on the scientific rationale behind the use of NK cell therapy for the treatment of Parkinson's disease. Dr. Song will also present clinical safety and efficacy data from the Company's recently completed Phase 1 clinical trial evaluating autologous SNK01 NK cell therapy in patients with Alzheimer's disease (NCT04678453).
A copy of the presentation will be available on the Scientific Publications page of the Company's website at https://nkgenbiotech.com/ once the presentation has concluded. Previously disclosed Phase 1 data on the positive effects of SNK01 on amyloid, tau and neuroinflammation biomarkers, which may not be included in this conference presentation, can also be found on the Scientific Publications page.
You are dead wrong
NKGN became associate company now and IPO thru spac merger last year
Nothing to do with NK Max in Korea
NKGN
Huge news out now
BPTH
exploding to $10
750k OS
BPTH
Monster
ATHE
last chance before $5 Monday premkt
I was telling to buy at $2.20
Good luck all
ATHE
keep going up
Huge P2 data presentation on 04/14 Sunday
100% pop coming Monday morning
ATHE
just broke $3
ATHE
exploding
Just starting
100% on Monday
ATHE
exploding in anticipation of P2 data release on 04/14 presentation
100% pop on Monday
ATHE
exploding in anticipation of P2 data presentation on Sunday
100% explosion on huge P2 news coming
Huge P2 interim result for Alzheimer is coming soon
Billion dollar mktcap potential
1000% run coming
NKGN
moving up
Huge P2 interim result for Alzheimer coming up soon
1000% run coming
ANGH
exploding
OSN group will keep buying upto $3.69
ANGH
$4.3 billion OSN group paid $3.69 for majority shares
Pps will keep going up
ANGH
exploding now
Filthy rich Dubai media giant took majority shares at $3.69 per shares
ANGH
$4.3 billion Dubai OSN group bought 62% shares as per last night 13D filing
OSN group paid $3.69 for 37 mil majority shares and added 13 mil more shares in open mkt totaling 50 mil shares
They won’t Pps sit low $1.45
They mean business
ANGH
will explode over $2 tmrw
$4.3 billion OSN group keep buying the shares in open market
Good luck
ANGH
keep going up
$4.3 billion Dubai OSN keep buying shares now as I said
They paid $3.69 per share
ANGH
exploding huge
Buy before $2
ANGH will explode over $2 tmrw
Huge 13D filed just now
Thus will explode over $1 tmrw
$4.3 billion Dubai OSN group purchased 63% of total shares now as per 13D filing
https://www.otcmarkets.com/filing/html?id=17437819&guid=BRQ-k6RnR1BGB3h
ANGH
$4.3 billion Dubai OSN group keep buying the shares as said before
OSN group holding around 63% total OS now
https://www.otcmarkets.com/filing/html?id=17437819&guid=BRQ-k6RnR1BGB3h
ANGH
Huge 13D just filed
https://www.otcmarkets.com/filing/html?id=17437819&guid=BRQ-k6RnR1BGB3h